Acrivon Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $599k | 331k | 1.81 |
| 2025-06-30 | $485k | 408k | 1.19 |
| 2025-03-31 | $1.9M | 939k | 2.03 |
| 2024-12-31 | $5.7M | 946k | 6.02 |
| 2024-09-30 | $5.5M | 787k | 7.00 |